Celebrating 30 years of helping you give wisely
America's most independent,
assertive charity watchdog
Top Rated

Breast Cancer Research Foundation

CharityWatch report issued
November 2021

Top-Rated Charity
CharityWatch Grade
Our independent grade based
on a number of factors.
Program Percentage
Amount spent on programs
relative to overhead.
Cost to Raise $100
Amount spent to raise
$100 of contributions.

Contact Information

Breast Cancer Research Foundation
28 W 44th St
Ste 609
New York, NY 10036

Other Names


Tax Status




Stated Mission

To prevent and cure breast cancer by advancing the world's most promising research.

View similar charities
American Breast Cancer Foundation  
American Cancer Society  
American Institute for Cancer Research  
Avon Products Foundation  
Breast Cancer Charities of America (DISSOLVED)  
Breast Cancer Outreach Foundation (DISSOLVED)  
Breast Cancer Prevention Partners  
Breast Cancer Society (DISSOLVED)  
Cancer Fund of America (DISSOLVED)  
Cancer Recovery Foundation International  
Cancer Research Institute  
Cancer Survivors' Fund (DISSOLVED)  
Childhood Leukemia Foundation  
Children's Cancer Fund of America (DISSOLVED)  
Children's Cancer Recovery Foundation (DISSOLVED)  
Children's Cancer Research Fund  
Children's Leukemia Research Association  
CureSearch for Children's Cancer  
Damon Runyon Cancer Research Foundation  
Dana-Farber Cancer Institute  
Entertainment Industry Foundation / Stand Up To Cancer  
Good Charity (DISSOLVED)  
Leukemia & Lymphoma Society  
Livestrong Foundation  
Memorial Sloan Kettering Cancer Center  
Movember Foundation  
Multiple Myeloma Research Foundation  
National Breast Cancer Coalition Fund  
National Breast Cancer Foundation  
National Cancer Assistance Foundation  
National Cancer Center  
National Cancer Coalition (DISSOLVED)  
National Children's Cancer Society  
National Children's Leukemia Foundation (DISSOLVED)  
National Foundation for Cancer Research  
Ovarian Cancer Research Alliance  
Pancreatic Cancer Action Network  
Prevent Cancer Foundation  
Prostate Cancer Foundation  
St. Jude Children's Research Hospital  
Susan G. Komen Breast Cancer Foundation  
United Breast Cancer Foundation  
United Cancer Support Foundation  
Walker Cancer Research Institute  
Woman to Woman Breast Cancer Foundation (DISSOLVED)  
Data based on Fiscal Year Ended 06/30/2020

Program Percentage: 81%

The percentage of Breast Cancer Research Foundation's cash budget it spends on programs relative to overhead (fundraising, management, and general expenses).


Calculated Total Expenses



Cost to Raise $100: $10

How many dollars Breast Cancer Research Foundation spends on fundraising to raise each $100 of contributions.


Calculated Total Contributions


Government Funding

0% to 24%

Percentage of cash revenue
coming from government sources


Financial Documents

Entity Document Type Tax ID
The Breast Cancer Research Foundation IRS Form 990 13-3727250
The Breast Cancer Research Foundation Audited Consolidated Financial Statements multiple
Entity: The Breast Cancer Research Foundation
Document Type: IRS Form 990
Tax ID: 13-3727250
Entity: The Breast Cancer Research Foundation
Document Type: Audited Consolidated Financial Statements
Tax ID: multiple

Governance & Transparency

CharityWatch evaluates certain criteria related to a charity's Governance and Transparency. Donors may want to consider a charity's willingness to be open and transparent with CharityWatch to be a good litmus test for determining its commitment to public accountability.
This charity is Top-Rated
What does it mean to be Top-Rated?
Breast Cancer Research Foundation
meets governance benchmarks.
Breast Cancer Research Foundation
meets transparency benchmarks.
Provides Financial Information
Audit Accessibility
Governance: Policies
Reports regularly & consistently monitoring & enforcing compliance with a written Conflict of Interest Policy
Reports required, annual disclosure by officers, directors, and key staff of interests that could give rise to conflicts
Reports having a written Whistleblower Policy
Reports having a written Document Retention and Destruction Policy
Governance: Financials
Reports providing copy of tax form to all board members prior to filing it with IRS
Reports that financial statements were audited by an independent accountant
Governance: Board of Directors
Reports at least 5 voting board members
51% or more of voting board members reported as independent
Reports documenting minutes of board and board committee meetings
Privacy Policy
Privacy Policy No Sharing  

  Name Title Compensation
1 Myra Biblowit President/CEO $828,063
2 Lucretia Gilbert Chief Development Officer $355,728
3 Lisa Risi COO $337,502
Name: Myra Biblowit
Title: President/CEO
Compensation: $828,063
Name: Lucretia Gilbert
Title: Chief Development Officer
Compensation: $355,728
Name: Lisa Risi
Title: COO
Compensation: $337,502

CharityWatch Analysts perform an in-depth analysis of charities' audited financial statements and IRS tax filings, and often review other documents such as state filings, annual reports, and fundraising contracts during their evaluations. Below are select notes that CharityWatch believes may be of interest to donors.

CharityWatch's rating of The Breast Cancer Research Foundation (BCRF) also includes the financial activities of The Breast Cancer Research Foundation in Canada, which are consolidated in BCRF's audited financial statements for the fiscal year ended June 30, 2020.

According to The Breast Cancer Research Foundation (BCRF) consolidated audit of June 30, 2020 (Note A-1, The Foundation):

"The Breast Cancer Research Foundation in Canada ('BCRF Canada') is an officially registered tax-exempt charity in Canada. As this entity meets the criteria for consolidation, its financial statements are consolidated with those of BCRF... All significant inter-organization balances and transactions have been eliminated in consolidation."

According to The Breast Cancer Research Foundation (BCRF) consolidated audit of June 30, 2020 (Note H, Donated Goods and Services), BCRF received donated goods and services in fiscal 2020 on which it placed a total value of $733,810.

[Note: CharityWatch generally excludes the value of in-kind (non-cash) donations of goods and services from its calculations of Program % and Cost to Raise $100. More information on how grades are calculated and the treatment of in-kind donations can be found on the Our Process page.]

According to The Breast Cancer Research Foundation consolidated audit of June 30, 2020 (Note L, PPP Loan Payable):

"On May 1, 2020, the Foundation received $1,272,100 in funds from the PPP [Paycheck Protection Program]... Neither principal nor interest is due for a ten-month deferral period from the last day of the Foundation's covered period, which is October 15, 2021. This loan may be forgiven subject to bank approval in accordance with SBA [Small Business Administration] guidelines. Any outstanding principle of the loan that is not forgiven under the PPP Loan program at the end of the ten-month deferral period will convert to a term loan with an interest rate of 0.98% payable in equal installments of principle and interest over the next twenty-four months, beginning in February 2021. The loan matures on May 1, 2022. The Foundation is in the process of applying for forgiveness."

According to The Breast Cancer Research Foundation consolidated audit of June 30, 2020 (Note J-1, Related-Party Transactions, Fund-raising):

"One member of the Foundation's Board of Directors is also a member of the Board of Directors of a corporation that donated a portion of its sales revenue to the Foundation and held various fund-raising events for the benefit of the Foundation. For fiscal-years 2020 and 2019, the Foundation recognized contribution revenue from the corporation of approximately $6,994,000 and $8,224,000 respectively..."

According to The Breast Cancer Research Foundation consolidated audit of June 30, 2020 (Note J-2, Related-Party Transactions, Operating expenses):

"The Foundation also reimburses this corporation to cover certain operating expenses paid on its behalf each fiscal year. These reimbursements to the corporation are for payroll and related benefits for the staff who exclusively conduct the Foundation's activities, as well as reimbursement for other administrative services provided at cost. For fiscal years 2020 and 2019, these reimbursements approximated $9,413,000 and $7,932,000, respectively..."

Related to Audit Note J-2, cited above, according to The Breast Cancer Research Foundation (BCRF) fiscal 2020 tax filing, BCRF reports re: Business Transactions Involving Interested Persons:

"William Lauder is a member of the Board of Directors of The Breast Cancer Research Foundation as well as the Executive Chairman of the Estee Lauder Companies. The Foundation reimburses Estee Lauder for payroll and benefits for the Foundation's staff who exclusively conduct the Foundation's activities, as well as for miscellaneous fund-raising and office expenses" (IRS Form 990, Schedule L, Part V). 

According to The Breast Cancer Research Foundation consolidated audit of June 30, 2020 (Note K-2, Commitments, Employment agreement):

"The Foundation is obligated under an employment agreement with its President. The agreement is automatically extended on an annual basis, unless either party provides 90 days of prior written notice of its intention not to do so."

According to The Breast Cancer Research Foundation consolidated audit of June 30, 2020 (Note K-5, Other uncertainty):

"The extent of the impact of the coronavirus ('COVID-19') outbreak on the operational and financial performance of the Foundation will depend on the continued future developments, including the duration and spread of the outbreak and related travel advisories and restrictions and the impact of COVID-19 on the overall availability of contributions towards the Foundation's programs, all of which are highly uncertain and cannot be predicted. If contributions towards the Foundation's programs are impacted for an extended period, results of operations may be materially adversely affected.

"The Foundation retained over $18 million in net income in FY2020 to provide additional fiscal support to offset the potential impact of COVID-19 on the Foundation's operations."

According to The Breast Cancer Research Foundation (BCRF) tax filing for the fiscal year ended June 30, 2020, BCRF reports re: Compensation, Supplemental Information (IRS Form 990, Schedule J, Part III):

Regarding nonfixed payments to officers, directors, trustees, key employees and highest compensated employees (Schedule J, Part I, Line 7):

"In the prior year, the Foundation's board of directors authorized a bonus for the president which was paid to her in the current year."

BCRF reports "Bonus & incentive compensation" in the amount of $50,000 paid to Myra Biblowit, President & CEO; her reported total compensation in calendar year 2019 is $828,063 (IRS Form 990, Schedule J, Part II).

Related External Articles